Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study.
Saved in:
| Title: | Improvement in lipids after switch to boosted atazanavir or darunavir in children/adolescents with perinatally acquired HIV on older protease inhibitors: results from the Pediatric HIV/AIDS Cohort Study. |
|---|---|
| Authors: | Jao, J.1 jennifer.jao@mssm.edu, Yu, W.2, Patel, K.3, Miller, T. L.4, Karalius, B.3, Geffner, M. E.5, DiMeglio, L. A.6, Mirza, A.7, Chen, J. S.8, Silio, M.9, McFarland, E. J.10, Van Dyke, R. B.9, Jacobson, D.2, the Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol (AMP) study |
| Source: | HIV Medicine. Mar2018, Vol. 19 Issue 3, p175-183. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14642662 |
|---|---|
| DOI: | 10.1111/hiv.12566 |
